These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27143303)

  • 1. IL-22-induced antimicrobial peptides are key determinants of mucosal vaccine-induced protection against H. pylori in mice.
    Moyat M; Bouzourene H; Ouyang W; Iovanna J; Renauld JC; Velin D
    Mucosal Immunol; 2017 Jan; 10(1):271-281. PubMed ID: 27143303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
    Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
    Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
    Yang J; Dai LX; Pan X; Wang H; Li B; Zhu J; Li MY; Shi XL; Wang BN
    Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25846576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses.
    Ermak TH; Giannasca PJ; Nichols R; Myers GA; Nedrud J; Weltzin R; Lee CK; Kleanthous H; Monath TP
    J Exp Med; 1998 Dec; 188(12):2277-88. PubMed ID: 9858514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model.
    Velin D; Favre L; Bernasconi E; Bachmann D; Pythoud C; Saiji E; Bouzourene H; Michetti P
    Gastroenterology; 2009 Jun; 136(7):2237-2246.e1. PubMed ID: 19272385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcomponent vaccine based on CTA1-DD adjuvant with incorporated UreB class II peptides stimulates protective Helicobacter pylori immunity.
    Nedrud JG; Bagheri N; Schön K; Xin W; Bergroth H; Eliasson DG; Lycke NY
    PLoS One; 2013; 8(12):e83321. PubMed ID: 24391754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection Against
    Pan X; Ke H; Niu X; Li S; Lv J; Pan L
    Front Immunol; 2018; 9():1003. PubMed ID: 29867978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
    Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
    Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-epitope vaccine CTB-UE relieves Helicobacter pylori-induced gastric inflammatory reaction via up-regulating microRNA-155 to inhibit Th17 response in C57/BL6 mice model.
    Lv X; Song H; Yang J; Li T; Xi T; Xing Y
    Hum Vaccin Immunother; 2014; 10(12):3561-9. PubMed ID: 25483699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
    Li X; Xing Y; Guo L; Lv X; Song H; Xi T
    Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of oral immunization with a non-genetically modified Lactococcus lactis-based vaccine CUE-GEM induces local immunity against Helicobacter pylori infection.
    Liu W; Tan Z; Xue J; Luo W; Song H; Lv X; Zheng T; Xi T; Xing Y
    Appl Microbiol Biotechnol; 2016 Jul; 100(14):6219-6229. PubMed ID: 26846746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAR2 promotes vaccine-induced protection against Helicobacter infection in mice.
    Velin D; Narayan S; Bernasconi E; Busso N; Ramelli G; Maillard MH; Bachmann D; Pythoud C; Bouzourene H; Michetti P; So A
    Gastroenterology; 2011 Oct; 141(4):1273-82, 1282.e1. PubMed ID: 21703999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant.
    Zhang HX; Qiu YY; Zhao YH; Liu XT; Liu M; Yu AL
    Mol Cell Probes; 2014 Feb; 28(1):25-30. PubMed ID: 24036137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization.
    Sjökvist Ottsjö L; Jeverstam F; Yrlid L; Wenzel AU; Walduck AK; Raghavan S
    Immunology; 2017 Feb; 150(2):172-183. PubMed ID: 27676456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency of circulating integrin α4β7
    Akter S; Jeverstam F; Lundgren A; Magnusson MK; Walduck A; Qadri F; Bhuiyan TR; Raghavan S
    Helicobacter; 2019 Dec; 24(6):e12658. PubMed ID: 31502365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: an important role for interleukin-17 during the effector phase.
    Flach CF; Östberg AK; Nilsson AT; Malefyt Rde W; Raghavan S
    Infect Immun; 2011 Feb; 79(2):879-86. PubMed ID: 21078851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Bacillus subtilis spores expressing cholera toxin B subunit and Helicobacter pylori urease B confer protection against H. pylori in mice.
    Zhou Z; Dong H; Huang Y; Yao S; Liang B; Xie Y; Long Y; Mai J; Gong S
    J Med Microbiol; 2017 Jan; 66(1):83-89. PubMed ID: 27930268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against Helicobacter pylori infection by a trivalent fusion vaccine based on a fragment of urease B-UreB414.
    Wang L; Liu XF; Yun S; Yuan XP; Mao XH; Wu C; Zhang WJ; Liu KY; Guo G; Lu DS; Tong WD; Wen AD; Zou QM
    J Microbiol; 2010 Apr; 48(2):223-8. PubMed ID: 20437155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of local immune response in gastric mucosa in the protection induced by Helicobacter pylori vaccine with chitosan as adjuvant].
    Xie Y; Gong YF; Zhou NJ; Chen J; Zhou XJ; Lü NH; Wang CW
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2629-35. PubMed ID: 16321324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils.
    Guo L; Yin R; Xu G; Gong X; Chang Z; Hong D; Liu H; Ding S; Han X; Li Y; Tang F; Liu K
    Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28851031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.